Tag: anaphylaxis market share

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Anaphylaxis Market Revenue Growth Supported By A CAGR Of 5.14% Through 2030

The anaphylaxis market experienced robust expansion recently, projected to increase from $3.5 billion in 2025 to $3.79 billion in 2026, reflecting a compound annual growth rate of 8.2%. This upward trajectory in the past is linked to several factors, including a surge in food and medication allergies, enhanced detection of allergic diseases, the accessibility of immediate epinephrine therapies, heightened public health consciousness, and the implementation of uniform treatment protocols.

The anaphylaxis market is poised for substantial expansion over the coming years, projecting a reach of $5.14 billion by 2030 with a compound annual growth rate (CAGR) of 7.9%. This anticipated growth stems from several key factors, including improved accessibility to emergency allergy treatment, a heightened demand for easily transportable therapeutic options, the broadening scope of specialized allergy services, a greater emphasis on patient education initiatives, and increased financial commitment to allergy management infrastructure. During this forecast period, prominent trends expected to influence the market include a greater availability of epinephrine auto-injectors, heightened public awareness regarding severe allergic reactions, an increased focus on readiness for emergencies, advancements in allergy diagnosis and ongoing patient monitoring, and a more pronounced emphasis on rapid response strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Anaphylaxis Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing incidence of food allergies is anticipated to steer the expansion of the anaphylaxis market in the future. These allergies, characterized by the immune system’s overreaction to specific food components, can manifest in a spectrum of symptoms, from minor discomfort to severe, potentially fatal anaphylaxis. Factors contributing to this rise include shifts in eating patterns, environmental elements, and heightened awareness and diagnostic capabilities. Anaphylaxis management serves as a crucial, life-saving measure for those with food allergies, swiftly counteracting severe allergic responses by alleviating symptoms like edema, respiratory distress, and hypotension, thereby ensuring immediate stabilization and averting fatalities, while also equipping individuals with the means for prompt action during subsequent allergic events. As an illustration, by September 2024, global estimates from the World Health Organization (WHO), a United Nations entity headquartered in Switzerland, indicated that approximately 220 million individuals worldwide contend with food allergies. It is noteworthy that a single food item might contain multiple allergens, and individuals can exhibit sensitivities to a variety of foods. Furthermore, data from May 2024, presented in the Patterns and Prevalence of Adult Food Allergy (PAFA) report by the UK’s Food Standards Agency (FSA), revealed that more than 30% of adults reported adverse reactions associated with food, with around 6% of UK adults, totaling roughly 2.4 million people, confirmed to have clinical food allergies. Consequently, the escalating rate of food allergies is a significant driver for the growth observed in the anaphylaxis market.

Anaphylaxis Market Segment Performance And Strategic Opportunities

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Anaphylaxis Market Trends Reshaping Industry Growth

The anaphylaxis market is witnessing significant activity from key players concentrating on the creation of cutting-edge epinephrine nasal sprays designed for enhanced and swifter medication administration in urgent circumstances. This medical apparatus functions by dispensing epinephrine, also known as adrenaline, via the nasal route to address serious allergic responses, anaphylaxis included. As an illustration, ARS Pharmaceuticals, a biotechnology firm based in the United States, revealed in August 2024 the Food and Drug Administration’s approval of Neffy, its epinephrine nasal spray; this development signifies the introduction of the inaugural and exclusive needle-free therapy for type I allergic reactions, encompassing anaphylaxis. This novel nasal spray presents a non-penetrating substitute to conventional epinephrine auto-injectors, potentially offering a more readily available solution for emergency interventions, and through its needle-free approach, Neffy seeks to boost patient adherence while ensuring prompt, life-saving epinephrine delivery during acute allergic events.

Anaphylaxis Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Access The Complete Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Anaphylaxis Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Anaphylaxis Market Revenue Growth Supported By A CAGR Of 5.14% Through 2030

The anaphylaxis market experienced robust expansion recently, projected to increase from $3.5 billion in 2025 to $3.79 billion in 2026, reflecting a compound annual growth rate of 8.2%. This upward trajectory in the past is linked to several factors, including a surge in food and medication allergies, enhanced detection of allergic diseases, the accessibility of immediate epinephrine therapies, heightened public health consciousness, and the implementation of uniform treatment protocols.

The anaphylaxis market is poised for substantial expansion over the coming years, projecting a reach of $5.14 billion by 2030 with a compound annual growth rate (CAGR) of 7.9%. This anticipated growth stems from several key factors, including improved accessibility to emergency allergy treatment, a heightened demand for easily transportable therapeutic options, the broadening scope of specialized allergy services, a greater emphasis on patient education initiatives, and increased financial commitment to allergy management infrastructure. During this forecast period, prominent trends expected to influence the market include a greater availability of epinephrine auto-injectors, heightened public awareness regarding severe allergic reactions, an increased focus on readiness for emergencies, advancements in allergy diagnosis and ongoing patient monitoring, and a more pronounced emphasis on rapid response strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Anaphylaxis Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing incidence of food allergies is anticipated to steer the expansion of the anaphylaxis market in the future. These allergies, characterized by the immune system’s overreaction to specific food components, can manifest in a spectrum of symptoms, from minor discomfort to severe, potentially fatal anaphylaxis. Factors contributing to this rise include shifts in eating patterns, environmental elements, and heightened awareness and diagnostic capabilities. Anaphylaxis management serves as a crucial, life-saving measure for those with food allergies, swiftly counteracting severe allergic responses by alleviating symptoms like edema, respiratory distress, and hypotension, thereby ensuring immediate stabilization and averting fatalities, while also equipping individuals with the means for prompt action during subsequent allergic events. As an illustration, by September 2024, global estimates from the World Health Organization (WHO), a United Nations entity headquartered in Switzerland, indicated that approximately 220 million individuals worldwide contend with food allergies. It is noteworthy that a single food item might contain multiple allergens, and individuals can exhibit sensitivities to a variety of foods. Furthermore, data from May 2024, presented in the Patterns and Prevalence of Adult Food Allergy (PAFA) report by the UK’s Food Standards Agency (FSA), revealed that more than 30% of adults reported adverse reactions associated with food, with around 6% of UK adults, totaling roughly 2.4 million people, confirmed to have clinical food allergies. Consequently, the escalating rate of food allergies is a significant driver for the growth observed in the anaphylaxis market.

Anaphylaxis Market Segment Performance And Strategic Opportunities

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Anaphylaxis Market Trends Reshaping Industry Growth

The anaphylaxis market is witnessing significant activity from key players concentrating on the creation of cutting-edge epinephrine nasal sprays designed for enhanced and swifter medication administration in urgent circumstances. This medical apparatus functions by dispensing epinephrine, also known as adrenaline, via the nasal route to address serious allergic responses, anaphylaxis included. As an illustration, ARS Pharmaceuticals, a biotechnology firm based in the United States, revealed in August 2024 the Food and Drug Administration’s approval of Neffy, its epinephrine nasal spray; this development signifies the introduction of the inaugural and exclusive needle-free therapy for type I allergic reactions, encompassing anaphylaxis. This novel nasal spray presents a non-penetrating substitute to conventional epinephrine auto-injectors, potentially offering a more readily available solution for emergency interventions, and through its needle-free approach, Neffy seeks to boost patient adherence while ensuring prompt, life-saving epinephrine delivery during acute allergic events.

Anaphylaxis Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Access The Complete Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Anaphylaxis Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Enhanced with market attractiveness analysis, total addressable market evaluation, company benchmarking matrices, interactive Excel dashboards, expanded supply chain intelligence, emerging startup coverage, and detailed product insights, The Business Research Company’s 2026 market reports deliver more actionable and strategically valuable research.

Anaphylaxis Market Revenue Growth Supported By A CAGR Of 5.14% Through 2030

The anaphylaxis market experienced robust expansion recently, projected to increase from $3.5 billion in 2025 to $3.79 billion in 2026, reflecting a compound annual growth rate of 8.2%. This upward trajectory in the past is linked to several factors, including a surge in food and medication allergies, enhanced detection of allergic diseases, the accessibility of immediate epinephrine therapies, heightened public health consciousness, and the implementation of uniform treatment protocols.

The anaphylaxis market is poised for substantial expansion over the coming years, projecting a reach of $5.14 billion by 2030 with a compound annual growth rate (CAGR) of 7.9%. This anticipated growth stems from several key factors, including improved accessibility to emergency allergy treatment, a heightened demand for easily transportable therapeutic options, the broadening scope of specialized allergy services, a greater emphasis on patient education initiatives, and increased financial commitment to allergy management infrastructure. During this forecast period, prominent trends expected to influence the market include a greater availability of epinephrine auto-injectors, heightened public awareness regarding severe allergic reactions, an increased focus on readiness for emergencies, advancements in allergy diagnosis and ongoing patient monitoring, and a more pronounced emphasis on rapid response strategies.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

Anaphylaxis Market Growth Momentum: Which Factors Are Influencing Demand?

The increasing incidence of food allergies is anticipated to steer the expansion of the anaphylaxis market in the future. These allergies, characterized by the immune system’s overreaction to specific food components, can manifest in a spectrum of symptoms, from minor discomfort to severe, potentially fatal anaphylaxis. Factors contributing to this rise include shifts in eating patterns, environmental elements, and heightened awareness and diagnostic capabilities. Anaphylaxis management serves as a crucial, life-saving measure for those with food allergies, swiftly counteracting severe allergic responses by alleviating symptoms like edema, respiratory distress, and hypotension, thereby ensuring immediate stabilization and averting fatalities, while also equipping individuals with the means for prompt action during subsequent allergic events. As an illustration, by September 2024, global estimates from the World Health Organization (WHO), a United Nations entity headquartered in Switzerland, indicated that approximately 220 million individuals worldwide contend with food allergies. It is noteworthy that a single food item might contain multiple allergens, and individuals can exhibit sensitivities to a variety of foods. Furthermore, data from May 2024, presented in the Patterns and Prevalence of Adult Food Allergy (PAFA) report by the UK’s Food Standards Agency (FSA), revealed that more than 30% of adults reported adverse reactions associated with food, with around 6% of UK adults, totaling roughly 2.4 million people, confirmed to have clinical food allergies. Consequently, the escalating rate of food allergies is a significant driver for the growth observed in the anaphylaxis market.

Anaphylaxis Market Segment Performance And Strategic Opportunities

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

Anaphylaxis Market Trends Reshaping Industry Growth

The anaphylaxis market is witnessing significant activity from key players concentrating on the creation of cutting-edge epinephrine nasal sprays designed for enhanced and swifter medication administration in urgent circumstances. This medical apparatus functions by dispensing epinephrine, also known as adrenaline, via the nasal route to address serious allergic responses, anaphylaxis included. As an illustration, ARS Pharmaceuticals, a biotechnology firm based in the United States, revealed in August 2024 the Food and Drug Administration’s approval of Neffy, its epinephrine nasal spray; this development signifies the introduction of the inaugural and exclusive needle-free therapy for type I allergic reactions, encompassing anaphylaxis. This novel nasal spray presents a non-penetrating substitute to conventional epinephrine auto-injectors, potentially offering a more readily available solution for emergency interventions, and through its needle-free approach, Neffy seeks to boost patient adherence while ensuring prompt, life-saving epinephrine delivery during acute allergic events.

Anaphylaxis Market Key Players: Which Companies Shape Industry Competition?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Access The Complete Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Anaphylaxis Market Leading Geography: Which Region Generates The Most Revenue?

North Americawas the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Anaphylaxis Market Expected To Reach Based On Its 2026 Value?

The anaphylaxis market size has seen strong expansion in recent years. It is forecast to rise from $3.5 billion in 2025 to $3.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to a heightened incidence of food and drug allergies, more frequent diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, increasing public health awareness, and the adoption of consistent treatment guidelines.

The market for anaphylaxis treatments is projected to experience robust expansion in the coming years. This market is forecast to reach $5.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the projection period include improved access to urgent allergy care, an increased need for portable treatment options, the broadening of allergy specialty services, a heightened emphasis on patient education initiatives, and greater investment in allergy management systems. Key trends anticipated over the forecast timeframe involve the wider availability of epinephrine auto-injectors, a heightened understanding of severe allergic responses, an increased focus on readiness for emergencies, the advancement of allergy diagnosis and monitoring, and an improved emphasis on swift intervention protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

What Primary Drivers Are Shaping The Anaphylaxis Market?

The increasing incidence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming period. Food allergies manifest as immune responses provoked by specific food items, leading to symptoms ranging from minor to critical, such as severe anaphylaxis, which can be fatal. This growing occurrence of food allergies stems from elements like evolving dietary patterns, environmental factors, and enhanced diagnostic capabilities and public awareness. Anaphylaxis treatment offers essential, life-saving care for individuals with food allergies by quickly mitigating severe allergic responses; it alleviates symptoms like swelling, respiratory distress, and decreased blood pressure, ensuring prompt stabilization and averting potentially deadly results, concurrently equipping patients to act swiftly during subsequent allergic episodes. For example, data from September 2024, released by the World Health Organization (WHO), a Switzerland-based United Nations (UN) entity, indicates that approximately 220 million individuals worldwide suffer from food allergies. A sole food item might contain various allergens, and people can be sensitive to more than one kind of food. Furthermore, the Patterns and Prevalence of Adult Food Allergy (PAFA) report from May 2024, issued by the Food Standards Agency (FSA), a UK-based non-ministerial department, stated that more than 30% of adults reported adverse reactions linked to food, with clinical evaluations confirming food allergies in about 6% of UK adults, which amounts to around 2.4 million individuals. Consequently, the increasing prevalence of food allergies is propelling the expansion of the anaphylaxis market.

How Are Segments Identified Within The Anaphylaxis Market Segment Framework?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Trends Are Affecting The Growth Of The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal sprays, which enable faster, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) was approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Who Are The Companies Competing Within The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Get The Full Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Represents The Largest Share Of The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anaphylaxis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

Allergic Rhinitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Anaphylaxis Market Expected To Reach Based On Its 2026 Value?

The anaphylaxis market size has seen strong expansion in recent years. It is forecast to rise from $3.5 billion in 2025 to $3.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to a heightened incidence of food and drug allergies, more frequent diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, increasing public health awareness, and the adoption of consistent treatment guidelines.

The market for anaphylaxis treatments is projected to experience robust expansion in the coming years. This market is forecast to reach $5.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the projection period include improved access to urgent allergy care, an increased need for portable treatment options, the broadening of allergy specialty services, a heightened emphasis on patient education initiatives, and greater investment in allergy management systems. Key trends anticipated over the forecast timeframe involve the wider availability of epinephrine auto-injectors, a heightened understanding of severe allergic responses, an increased focus on readiness for emergencies, the advancement of allergy diagnosis and monitoring, and an improved emphasis on swift intervention protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

What Primary Drivers Are Shaping The Anaphylaxis Market?

The increasing incidence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming period. Food allergies manifest as immune responses provoked by specific food items, leading to symptoms ranging from minor to critical, such as severe anaphylaxis, which can be fatal. This growing occurrence of food allergies stems from elements like evolving dietary patterns, environmental factors, and enhanced diagnostic capabilities and public awareness. Anaphylaxis treatment offers essential, life-saving care for individuals with food allergies by quickly mitigating severe allergic responses; it alleviates symptoms like swelling, respiratory distress, and decreased blood pressure, ensuring prompt stabilization and averting potentially deadly results, concurrently equipping patients to act swiftly during subsequent allergic episodes. For example, data from September 2024, released by the World Health Organization (WHO), a Switzerland-based United Nations (UN) entity, indicates that approximately 220 million individuals worldwide suffer from food allergies. A sole food item might contain various allergens, and people can be sensitive to more than one kind of food. Furthermore, the Patterns and Prevalence of Adult Food Allergy (PAFA) report from May 2024, issued by the Food Standards Agency (FSA), a UK-based non-ministerial department, stated that more than 30% of adults reported adverse reactions linked to food, with clinical evaluations confirming food allergies in about 6% of UK adults, which amounts to around 2.4 million individuals. Consequently, the increasing prevalence of food allergies is propelling the expansion of the anaphylaxis market.

How Are Segments Identified Within The Anaphylaxis Market Segment Framework?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Trends Are Affecting The Growth Of The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal sprays, which enable faster, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) was approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Who Are The Companies Competing Within The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Get The Full Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Represents The Largest Share Of The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anaphylaxis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

Allergic Rhinitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

By 2030, What Market Size Is The Anaphylaxis Market Expected To Reach Based On Its 2026 Value?

The anaphylaxis market size has seen strong expansion in recent years. It is forecast to rise from $3.5 billion in 2025 to $3.79 billion in 2026, achieving a compound annual growth rate (CAGR) of 8.2%. This historical growth can be linked to a heightened incidence of food and drug allergies, more frequent diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, increasing public health awareness, and the adoption of consistent treatment guidelines.

The market for anaphylaxis treatments is projected to experience robust expansion in the coming years. This market is forecast to reach $5.14 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 7.9%. Factors contributing to this growth during the projection period include improved access to urgent allergy care, an increased need for portable treatment options, the broadening of allergy specialty services, a heightened emphasis on patient education initiatives, and greater investment in allergy management systems. Key trends anticipated over the forecast timeframe involve the wider availability of epinephrine auto-injectors, a heightened understanding of severe allergic responses, an increased focus on readiness for emergencies, the advancement of allergy diagnosis and monitoring, and an improved emphasis on swift intervention protocols.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

What Primary Drivers Are Shaping The Anaphylaxis Market?

The increasing incidence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming period. Food allergies manifest as immune responses provoked by specific food items, leading to symptoms ranging from minor to critical, such as severe anaphylaxis, which can be fatal. This growing occurrence of food allergies stems from elements like evolving dietary patterns, environmental factors, and enhanced diagnostic capabilities and public awareness. Anaphylaxis treatment offers essential, life-saving care for individuals with food allergies by quickly mitigating severe allergic responses; it alleviates symptoms like swelling, respiratory distress, and decreased blood pressure, ensuring prompt stabilization and averting potentially deadly results, concurrently equipping patients to act swiftly during subsequent allergic episodes. For example, data from September 2024, released by the World Health Organization (WHO), a Switzerland-based United Nations (UN) entity, indicates that approximately 220 million individuals worldwide suffer from food allergies. A sole food item might contain various allergens, and people can be sensitive to more than one kind of food. Furthermore, the Patterns and Prevalence of Adult Food Allergy (PAFA) report from May 2024, issued by the Food Standards Agency (FSA), a UK-based non-ministerial department, stated that more than 30% of adults reported adverse reactions linked to food, with clinical evaluations confirming food allergies in about 6% of UK adults, which amounts to around 2.4 million individuals. Consequently, the increasing prevalence of food allergies is propelling the expansion of the anaphylaxis market.

How Are Segments Identified Within The Anaphylaxis Market Segment Framework?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

What Trends Are Affecting The Growth Of The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are focusing on developing advanced epinephrine nasal sprays, which enable faster, more efficient drug delivery during emergencies. An epinephrine nasal spray is a medical device that delivers epinephrine (adrenaline) through the nasal passages as a treatment for severe allergic reactions, including anaphylaxis. For instance, in August 2024, ARS Pharmaceuticals, a US-based biotechnology company, announced Neffy (epinephrine nasal spray) was approved by the Food and Drug Administration, a US-based government agency, marking it as the first and only needle-free treatment for type I allergic reactions, including anaphylaxis. This innovative nasal spray provides a non-invasive alternative to traditional epinephrine autoinjectors, offering a potentially more accessible option for emergency treatment. Neffy aims to improve patient compliance by eliminating the need for needles while delivering rapid, life-saving epinephrine during severe allergic reactions.

Who Are The Companies Competing Within The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Get The Full Anaphylaxis Market Report:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Represents The Largest Share Of The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Anaphylaxis Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

Allergic Rhinitis Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Inhalable Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

Asthma Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Much Is The Anaphylaxis Market Expected To Grow In Terms Of Market Value Between 2026 And 2030?

The anaphylaxis market size has experienced robust growth over recent years. Projections indicate it will expand from $3.5 billion in 2025 to $3.79 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 8.2%. Historically, this expansion is attributable to several factors, including the rising incidence of food and drug allergies, an increased diagnosis of allergic conditions, the widespread availability of emergency epinephrine treatments, growing public health awareness, and the adoption of standardized treatment guidelines.

The anaphylaxis market size is anticipated to demonstrate significant expansion in the coming years, projected to reach $5.14 billion by 2030, at a compound annual growth rate (CAGR) of 7.9%. This growth throughout the forecast period stems from various factors including enhanced access to emergency allergy care, an increasing need for portable treatment solutions, the expansion of allergy specialty services, a heightened focus on patient education initiatives, and greater investment in allergy management infrastructure. Prominent trends for the forecast period encompass the growing availability of epinephrine auto-injectors, increased awareness concerning severe allergic reactions, a stronger emphasis on emergency preparedness, the broadening of allergy diagnosis and monitoring capabilities, and an improved focus on rapid response protocols.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=21096&type=smp

What Major Drivers Are Influencing Demand In The Anaphylaxis Market?

The increasing occurrence of food allergies is anticipated to drive the expansion of the anaphylaxis market in the coming years. Food allergies are immune system responses triggered by specific foods, manifesting in symptoms from mild to severe, including life-threatening anaphylaxis. This rising prevalence stems from factors such as changing dietary habits, environmental influences, and enhanced awareness and diagnosis. Anaphylaxis treatment provides crucial, life-saving intervention for food allergy patients by swiftly reversing severe allergic reactions, diminishing symptoms like swelling, difficulty breathing, and a drop in blood pressure, thus ensuring immediate stabilization and preventing potentially fatal outcomes. It also empowers patients with the means for timely action in future allergic incidents. For instance, in September 2024, the World Health Organization (WHO), a Switzerland-based United Nations (UN) organization, indicated that around 220 million people globally are affected by food allergies. A single food product can contain multiple allergens, and individuals might be allergic to more than one type of food. Additionally, a report published in May 2024, the Patterns and Prevalence of Adult Food Allergy (PAFA) by the Food Standards Agency (FSA), a UK-based non-ministerial department, revealed that over 30% of adults reported food-related adverse reactions, and clinical assessments confirmed food allergies in approximately 6% of UK adults, totaling around 2.4 million people. Therefore, the growing incidence of food allergies is fueling the growth of the anaphylaxis market.

What Major Segment Divisions Exist Within The Anaphylaxis Market?

The anaphylaxis market covered in this report is segmented –

1) By Drug Class: Epinephrine, Steroids, Antihistamines, Other Drug Class

2) By Route Of Administration: Parenteral, Oral, Other Routes Of Administration

3) By Application: Food Allergy, Pollen Allergy, Dust Mites Allergy, Other Applications

Subsegments:

1) By Epinephrine: Auto-injectors, Prefilled Syringes, Vials

2) By Steroids: Corticosteroids, Glucocorticoids, Mineralocorticoids

3) By Antihistamines: H1-receptor Antagonists, H2-receptor Antagonists

4) By Other Drug Class: Leukotriene Receptor Antagonists, Mast Cell Stabilizers

How Are Trends Shaping The Direction Of The Anaphylaxis Market?

Key players within the anaphylaxis market are concentrating on developing advanced epinephrine nasal spray products, which facilitate more rapid and effective drug administration in emergencies. An epinephrine nasal spray is a medical instrument that delivers epinephrine (adrenaline) via the nasal passages to manage severe allergic reactions, including anaphylaxis. For example, in August 2024, ARS Pharmaceuticals, a US-based biotechnology firm, announced that Neffy (epinephrine nasal spray) received approval from the Food and Drug Administration, a US-based government entity, establishing it as the initial and sole needle-free treatment for type I allergic reactions, including anaphylaxis. This inventive nasal spray offers a non-invasive substitute to traditional epinephrine autoinjectors, presenting a potentially more reachable solution for emergency intervention. Neffy endeavors to boost patient cooperation by removing the necessity for needles, while still supplying prompt, critical epinephrine during severe allergic responses.

Which Companies Are Leading Innovation In The Anaphylaxis Market?

Major companies operating in the anaphylaxis market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co. Inc., Bayer AG, Novartis AG, Sanofi SA, AstraZeneca plc, Abbott Laboratories, GlaxoSmithKline Plc, F. Hoffman-La Roche Ltd., Teva Pharmaceutical Industries Ltd., Bausch Health Companies Inc., Perrigo Company plc, Dr Reddy’s Laboratories Ltd., Cipla Ltd., Amneal Pharmaceuticals Inc., Mylan N.V., ALK-Abelló, Stallergenes Greer, Allergy Therapeutics

Read the full anaphylaxis market report here:

https://www.thebusinessresearchcompany.com/report/anaphylaxis-global-market-report

Which Region Shows The Strongest Potential For Future Growth In The Anaphylaxis Market?

North America was the largest region in the anaphylaxis market in 2025. The regions covered in the anaphylaxis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Anaphylaxis Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=21096&type=smp

Browse Through More Reports Similar to the Global Anaphylaxis Market 2026, By The Business Research Company

inhalable drugs global market report

https://www.thebusinessresearchcompany.com/report/inhalable-drugs-global-market-report

asthma drugs global market report

https://www.thebusinessresearchcompany.com/report/asthma-drugs-global-market-report

allergic rhinitis drugs global market report

https://www.thebusinessresearchcompany.com/report/allergic-rhinitis-drugs-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model